Stay updated on TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Sign up to get notified when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.

Latest updates to the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page
- Check2 days agoChange DetectedThe page shows a minor software revision update from v3.3.3 to v3.3.4; no study content, eligibility, or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedFooter updates: added 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' link.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this appears to be a generic page version update that does not affect study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedPublications section wording was updated to indicate that publications are automatically filled from PubMed, and the revision tag changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe funding-status banner was removed from the study record page; all substantive study details remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedThe two screenshots show mostly the same study details with minor UI layout adjustments and wording edits, and no changes to core study information such as outcomes or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.